Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera.

Guardado en:
Detalles Bibliográficos
Autores principales: Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, Li Guo, Ruixuan Guo, Ting Chen, Jiaxin Hu, Zichun Xiang, Zhixia Mu, Xing Chen, Jieyong Chen, Keping Hu, Qi Jin, Jianwei Wang, Zhaohui Qian
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/92d70903056e4689b4f7c4fd01947293
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92d70903056e4689b4f7c4fd01947293
record_format dspace
spelling oai:doaj.org-article:92d70903056e4689b4f7c4fd019472932021-12-02T17:31:09ZCharacterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV10.1038/s41467-020-15562-92041-1723https://doaj.org/article/92d70903056e4689b4f7c4fd019472932020-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15562-9https://doaj.org/toc/2041-1723SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera.Xiuyuan OuYan LiuXiaobo LeiPei LiDan MiLili RenLi GuoRuixuan GuoTing ChenJiaxin HuZichun XiangZhixia MuXing ChenJieyong ChenKeping HuQi JinJianwei WangZhaohui QianNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Xiuyuan Ou
Yan Liu
Xiaobo Lei
Pei Li
Dan Mi
Lili Ren
Li Guo
Ruixuan Guo
Ting Chen
Jiaxin Hu
Zichun Xiang
Zhixia Mu
Xing Chen
Jieyong Chen
Keping Hu
Qi Jin
Jianwei Wang
Zhaohui Qian
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
description SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera.
format article
author Xiuyuan Ou
Yan Liu
Xiaobo Lei
Pei Li
Dan Mi
Lili Ren
Li Guo
Ruixuan Guo
Ting Chen
Jiaxin Hu
Zichun Xiang
Zhixia Mu
Xing Chen
Jieyong Chen
Keping Hu
Qi Jin
Jianwei Wang
Zhaohui Qian
author_facet Xiuyuan Ou
Yan Liu
Xiaobo Lei
Pei Li
Dan Mi
Lili Ren
Li Guo
Ruixuan Guo
Ting Chen
Jiaxin Hu
Zichun Xiang
Zhixia Mu
Xing Chen
Jieyong Chen
Keping Hu
Qi Jin
Jianwei Wang
Zhaohui Qian
author_sort Xiuyuan Ou
title Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
title_short Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
title_full Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
title_fullStr Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
title_full_unstemmed Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
title_sort characterization of spike glycoprotein of sars-cov-2 on virus entry and its immune cross-reactivity with sars-cov
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/92d70903056e4689b4f7c4fd01947293
work_keys_str_mv AT xiuyuanou characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT yanliu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT xiaobolei characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT peili characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT danmi characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT liliren characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT liguo characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT ruixuanguo characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT tingchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT jiaxinhu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT zichunxiang characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT zhixiamu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT xingchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT jieyongchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT kepinghu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT qijin characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT jianweiwang characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
AT zhaohuiqian characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov
_version_ 1718380685899595776